Ovid Therapeutics Inc. Profile Avatar - Palmy Investing

Ovid Therapeutics Inc.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the …

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ovid Therapeutics Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Ovid Therapeutics Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Ovid Therapeutics Inc..

End of OVID's Analysis
CIK: 1636651 CUSIP: 690469101 ISIN: US6904691010 LEI: - UEI: -
Secondary Listings
OVID has no secondary listings inside our databases.